Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

103 matching registry records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:30 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3CompletedINTERVENTIONAL

Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

ClinicalTrials.gov · NCT06173531 · Registry updated: 2026-10-15

Condition / research focus: Hyperphagia in Prader-Willi Syndrome
Sponsor: ACADIA Pharmaceuticals Inc.
Countries with listed sites: Canada · France · Germany · Spain · United Kingdom · United States
Registry dates and results: Start: 2023-11-27. Completion: 2025-08-19 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: ACP-101
Placebo (drug)

Where the study takes place — 30 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Children's of Alabama
Birmingham, Alabama, United States
Site recruitment: Not reported
Phoenix Children's Hospital
Phoenix, Arizona, United States
Site recruitment: Not reported
University of California Irvine
Orange, California, United States
Site recruitment: Not reported
Stanford University School of Medicine
Palo Alto, California, United States
Site recruitment: Not reported
Rady Children's Hospital San Diego
San Diego, California, United States
Site recruitment: Not reported
Children's Hospital Colorado
Aurora, Colorado, United States
Site recruitment: Not reported
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Site recruitment: Not reported
University of Iowa
Iowa City, Iowa, United States
Site recruitment: Not reported
Boston Children's Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported
Children's Mercy Hospital
Kansas City, Missouri, United States
Site recruitment: Not reported
SSM Health/Saint Louis University
St Louis, Missouri, United States
Site recruitment: Not reported
Maimonides Medical Center
Brooklyn, New York, United States
Site recruitment: Not reported
Nationwide Children's Hospital
Columbus, Ohio, United States
Site recruitment: Not reported
UPMC-Children's Hospital Pittsburgh
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
Vanderbilt Clinical Research Center
Nashville, Tennessee, United States
Site recruitment: Not reported
Cook Children's Health Care System
Fort Worth, Texas, United States
Site recruitment: Not reported
Christus Children's
San Antonio, Texas, United States
Site recruitment: Not reported
University of Utah
Salt Lake City, Utah, United States
Site recruitment: Not reported
Seattle Children's Hospital
Seattle, Washington, United States
Site recruitment: Not reported
Alberta Diabetes Institute
Edmonton, Alberta, Canada
Site recruitment: Not reported
CHU Sainte Justine
Montreal, Quebec, Canada
Site recruitment: Not reported
Centre Hospitalier Universitaire (CHU) de Toulouse - Hôpital des Enfants
Toulouse, France
Site recruitment: Not reported
KJF Klinik Josefinum gGmbH
Augsburg, Germany
Site recruitment: Not reported
Universitätsklinikum Essen
Essen, Germany
Site recruitment: Not reported
Parc Taulí Hospital Universitari
Barcelona, Spain
Site recruitment: Not reported
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Site recruitment: Not reported
Hospital Regional Universitario de Málaga
Málaga, Spain
Site recruitment: Not reported
University Hospitals Birmingham NHS Foundation Trust - Heartlands Hospital
Birmingham, United Kingdom
Site recruitment: Not reported
Royal Hospital for Children Glasgow Clinical Research Facility
Glasgow, United Kingdom
Site recruitment: Not reported
Barts Health NHS Trust - The Royal London Hospital
London, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Carbetocin Monotherapy Versus Carbetocin Plus Oxytocin Infusion in Elective Cesarean Delivery: A Non-Inferiority Trial

ClinicalTrials.gov · NCT07636421 · Registry updated: 2026-10-09

Condition / research focus: Postpartum Hemorrhage; Uterine Atony; Cesarean Section; Blood Loss, Surgical
Sponsor: Mansoura University
Countries with listed sites: Saudi Arabia
Registry dates and results: Start: 2026-08-08. Completion: 2028-08 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin, Pabal
Oxytocin (drug) — also listed as: Syntocinon
Placebo Saline Infusion (drug) — also listed as: Normal Saline Placebo

Where the study takes place — 1 listed sites

Qassim University Medical City
Buraidah, Al-Qassim Region, Saudi Arabia
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

ClinicalTrials.gov · NCT06420297 · Registry updated: 2026-08-17

Condition / research focus: Hyperphagia in Prader-Willi Syndrome
Sponsor: ACADIA Pharmaceuticals Inc.
Countries with listed sites: Canada · France · Germany · Spain · United Kingdom · United States
Registry dates and results: Start: 2024-03-11. Completion: 2025-12-19 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: ACP-101

Where the study takes place — 30 listed sites

Children's of Alabama
Birmingham, Alabama, United States
Site recruitment: Not reported
Phoenix Children's Hospital
Phoenix, Arizona, United States
Site recruitment: Not reported
University of California Irvine
Orange, California, United States
Site recruitment: Not reported
Stanford University School of Medicine
Palo Alto, California, United States
Site recruitment: Not reported
Rady Children's Hospital San Diego
San Diego, California, United States
Site recruitment: Not reported
Children's Hospital Colorado
Aurora, Colorado, United States
Site recruitment: Not reported
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Site recruitment: Not reported
University of Iowa
Iowa City, Iowa, United States
Site recruitment: Not reported
Boston Children's Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported
Children's Mercy Kansas City
Kansas City, Missouri, United States
Site recruitment: Not reported
SSM Health/Saint Louis University
St Louis, Missouri, United States
Site recruitment: Not reported
Maimonides Medical Center
Brooklyn, New York, United States
Site recruitment: Not reported
Nationwide Children's Hospital
Columbus, Ohio, United States
Site recruitment: Not reported
UPMC-Children's Hospital Pittsburgh
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
Vanderbilt Clinical Research Center
Nashville, Tennessee, United States
Site recruitment: Not reported
Cook Children's Health Care System
Fort Worth, Texas, United States
Site recruitment: Not reported
Christus Children's
San Antonio, Texas, United States
Site recruitment: Not reported
University of Utah
Salt Lake City, Utah, United States
Site recruitment: Not reported
Seattle Children's Hospital
Seattle, Washington, United States
Site recruitment: Not reported
Alberta Diabetes Institute
Edmonton, Alberta, Canada
Site recruitment: Not reported
CHU Sainte-Justine
Montreal, Quebec, Canada
Site recruitment: Not reported
Centre Hospitalier Universitaire (CHU) de Toulouse - Hopital des Enfants
Toulouse, Cedex 9 Occitanie, France
Site recruitment: Not reported
KJF Klinik Josefinum gGmbH
Augsburg, Germany
Site recruitment: Not reported
Universitätsklinikum Essen
Essen, Germany
Site recruitment: Not reported
Parc Taulí Hospital Universitari
Barcelona, Spain
Site recruitment: Not reported
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Site recruitment: Not reported
Hospital Regional Universitario de Málaga
Málaga, Spain
Site recruitment: Not reported
University Hospitals Birmingham NHS Foundation Trust - Heartlands Hospital
Birmingham, United Kingdom
Site recruitment: Not reported
Royal Hospital for Children Glasgow Clinical
Glasgow, United Kingdom
Site recruitment: Not reported
Barts Health NHS Trust - The Royal London Hospital
London, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1Not yet recruitingINTERVENTIONAL

The Efficacy of Carbitocin in Reduction of Blood Loss During Myomectomy

ClinicalTrials.gov · NCT07721623 · Registry updated: 2026-07-23

Condition / research focus: Blood Loss, Surgical
Sponsor: Alex Ekwueme Federal University Teaching Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-08-15. Completion: 2028-08-14 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Injection water

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage

ClinicalTrials.gov · NCT07401524 · Registry updated: 2026-05-08

Condition / research focus: Postpartum Hemorrhage; Twin Pregnancy
Sponsor: Sheba Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2026-05-05. Completion: 2028-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Oxytocin (drug)

Where the study takes place — 1 listed sites

Sheba Medical Center
Ramat Gan, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium

ClinicalTrials.gov · NCT06285409 · Registry updated: 2026-04-06

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2024-04-04. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin
Oxytocin (drug) — also listed as: Pitocin
Carbetocin (drug) — also listed as: Duratocin
Oxytocin (drug) — also listed as: Pitocin
Ergonovine (drug) — also listed as: Ergometrine
Carboprost (drug) — also listed as: Hemabate

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery

ClinicalTrials.gov · NCT06333340 · Registry updated: 2026-04-01

Condition / research focus: Post Partum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2025-01-14. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Carbetocin (drug) — also listed as: Duratocin

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Effect of Co-administration of Carbetocin and Calcium Chloride on Uterine Tone in Patients Undergoing Elective Cesarean Delivery

ClinicalTrials.gov · NCT07187544 · Registry updated: 2026-04-01

Condition / research focus: Postpartum Hemorrhage (Primary)
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2025-12-01. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Calcium Chloride (drug)
Placebo (other)
Carbetocin (drug)

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparison of the Effect of Carbetocin Versus Oxytocin in the Prevention of Postpartum Hemorrhage After Emergency Caesarean Section in Antenatal Low-risk Patients

ClinicalTrials.gov · NCT07380529 · Registry updated: 2026-02-13

Condition / research focus: Postpartum Hemorrhage \(PPH\)
Sponsor: Ankara Etlik City Hospital
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2024-10-01. Completion: 2025-08-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Oxytocin (drug)

Where the study takes place — 2 listed sites

Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye)
Site recruitment: Not reported
Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Myocardium Trial 2014 Part 2

ClinicalTrials.gov · NCT03899961 · Registry updated: 2026-02-10

Condition / research focus: Pregnancy Complications
Sponsor: Oslo University Hospital
Countries with listed sites: Norway
Registry dates and results: Start: 2019-04-02. Completion: 2022-04-15 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Carbetocin (drug)

Where the study takes place — 2 listed sites

Akershus University Hospital
Lørenskog, Norway
Site recruitment: Not reported
Division of Anaesthesia and Intensive Care Medicine, Oslo University Hospital - Rikshospitalet
Oslo, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Ergometrine Versus Carbetocin to Decrease Blood Loss in Myomectomy

ClinicalTrials.gov · NCT07390864 · Registry updated: 2026-02-05

Condition / research focus: Myoma;Uterus
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2026-01-18. Completion: 2026-08-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Methylergometrine (Intramyometrial Injection) (drug) — also listed as: Methylergometrine maleate, Ergometrine, Methergine
Carbetocin (Intramyometrial Injection) (drug) — also listed as: Carbetocin, Long-acting oxytocin analogue

Where the study takes place — 1 listed sites

Fayoum University
Al Fayyum, Faiyum Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Carbetocin vs Misoprostol for Postpartum Hemorrhage Prevention

ClinicalTrials.gov · NCT07353281 · Registry updated: 2026-01-20

Condition / research focus: Postpartum Complication; Postpartum Hemorrhage
Sponsor: Western Galilee Hospital-Nahariya
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-01-31. Completion: 2028-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin 100 Microgram/mL Solution for Injection (drug)
Misoprostol (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone

ClinicalTrials.gov · NCT07318467 · Registry updated: 2026-01-06

Condition / research focus: Post Partum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-01-01. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative (drug)
Intravenous Carbetocin alone (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium

ClinicalTrials.gov · NCT06930391 · Registry updated: 2025-09-24

Condition / research focus: Postpartum Hemorrhage (Primary)
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2025-09-15. Completion: 2026-06 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Carbetocin (drug)
Calcium (drug)

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Timing of Carbetocin Administration in Postpartum Hemorrhage

ClinicalTrials.gov · NCT06776926 · Registry updated: 2025-09-18

Condition / research focus: Postpartum Hemorrhage; Carbetocin
Sponsor: Mehmet Mete Kırlangıç
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2025-01-10. Completion: 2025-02-28 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (behavioral)

Where the study takes place — 1 listed sites

Kartal Dr Lutfi Kirdar City Hospital
Istanbul, Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

To Compare the Effects of Oxytocin and Carbetocin on Intraoperative Hemodynamic Changes in Cesarean Section Surgeries.

ClinicalTrials.gov · NCT06956365 · Registry updated: 2025-05-04

Condition / research focus: Cesarean Section
Sponsor: Yuzuncu Yil University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2024-05-14. Completion: 2025-07-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Group-C (procedure) — also listed as: Group Carbetosin
Group-O (procedure) — also listed as: Group Oxytocine

Where the study takes place — 1 listed sites

Van Yuzuncu Yil University
Van, Tuşba, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4Not yet recruitingINTERVENTIONAL

Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section

ClinicalTrials.gov · NCT06946589 · Registry updated: 2025-04-27

Condition / research focus: Cardiac Ischemia; Cesarian Section
Sponsor: Jordan Leitch
Countries with listed sites: Canada
Registry dates and results: Start: 2025-08-01. Completion: 2027-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)

Where the study takes place — 1 listed sites

Kingston Health Sciences Centre
Kingston, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Carbetocin at Elective Cesarean Delivery

ClinicalTrials.gov · NCT01262742 · Registry updated: 2025-04-25

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2010-11. Completion: 2011-03 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin
Carbetocin (drug) — also listed as: Duratocin
Carbetocin (drug) — also listed as: Duratocin
Carbetocin (drug) — also listed as: Duratocin
Carbetocin (drug) — also listed as: Duratocin

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

ClinicalTrials.gov · NCT01968187 · Registry updated: 2025-03-27

Condition / research focus: Hyperphagia in Prader-Willi Syndrome
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2014-01-20. Completion: 2014-07-16 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

FE 992097 (drug)
Placebo (drug)

Where the study takes place — 3 listed sites

Florida University
Gainesville, Florida, United States
Site recruitment: Not reported
Winthrop University
Mineola, New York, United States
Site recruitment: Not reported
Vanderbilt University
Nashville, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative Pain

ClinicalTrials.gov · NCT06692621 · Registry updated: 2025-03-24

Condition / research focus: PREG1
Sponsor: Ankara City Hospital Bilkent
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2024-10-04. Completion: 2025-01-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Deva İlaç Sanayi, Turkey
Carbetocin (drug) — also listed as: Ferring GmbH, Germany

Where the study takes place — 1 listed sites

Ankara Bilkent City Hospital
Ankara, Ankara, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

103 matching registry records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:30 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3CompletedINTERVENTIONAL

Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

ClinicalTrials.gov · NCT06173531 · Registry updated: 2026-10-15

Condition / research focus: Hyperphagia in Prader-Willi Syndrome
Sponsor: ACADIA Pharmaceuticals Inc.
Countries with listed sites: Canada · France · Germany · Spain · United Kingdom · United States
Registry dates and results: Start: 2023-11-27. Completion: 2025-08-19 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: ACP-101
Placebo (drug)

Where the study takes place — 30 listed sites

Children's of Alabama
Birmingham, Alabama, United States
Site recruitment: Not reported
Phoenix Children's Hospital
Phoenix, Arizona, United States
Site recruitment: Not reported
University of California Irvine
Orange, California, United States
Site recruitment: Not reported
Stanford University School of Medicine
Palo Alto, California, United States
Site recruitment: Not reported
Rady Children's Hospital San Diego
San Diego, California, United States
Site recruitment: Not reported
Children's Hospital Colorado
Aurora, Colorado, United States
Site recruitment: Not reported
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Site recruitment: Not reported
University of Iowa
Iowa City, Iowa, United States
Site recruitment: Not reported
Boston Children's Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported
Children's Mercy Hospital
Kansas City, Missouri, United States
Site recruitment: Not reported
SSM Health/Saint Louis University
St Louis, Missouri, United States
Site recruitment: Not reported
Maimonides Medical Center
Brooklyn, New York, United States
Site recruitment: Not reported
Nationwide Children's Hospital
Columbus, Ohio, United States
Site recruitment: Not reported
UPMC-Children's Hospital Pittsburgh
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
Vanderbilt Clinical Research Center
Nashville, Tennessee, United States
Site recruitment: Not reported
Cook Children's Health Care System
Fort Worth, Texas, United States
Site recruitment: Not reported
Christus Children's
San Antonio, Texas, United States
Site recruitment: Not reported
University of Utah
Salt Lake City, Utah, United States
Site recruitment: Not reported
Seattle Children's Hospital
Seattle, Washington, United States
Site recruitment: Not reported
Alberta Diabetes Institute
Edmonton, Alberta, Canada
Site recruitment: Not reported
CHU Sainte Justine
Montreal, Quebec, Canada
Site recruitment: Not reported
Centre Hospitalier Universitaire (CHU) de Toulouse - Hôpital des Enfants
Toulouse, France
Site recruitment: Not reported
KJF Klinik Josefinum gGmbH
Augsburg, Germany
Site recruitment: Not reported
Universitätsklinikum Essen
Essen, Germany
Site recruitment: Not reported
Parc Taulí Hospital Universitari
Barcelona, Spain
Site recruitment: Not reported
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Site recruitment: Not reported
Hospital Regional Universitario de Málaga
Málaga, Spain
Site recruitment: Not reported
University Hospitals Birmingham NHS Foundation Trust - Heartlands Hospital
Birmingham, United Kingdom
Site recruitment: Not reported
Royal Hospital for Children Glasgow Clinical Research Facility
Glasgow, United Kingdom
Site recruitment: Not reported
Barts Health NHS Trust - The Royal London Hospital
London, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Carbetocin Monotherapy Versus Carbetocin Plus Oxytocin Infusion in Elective Cesarean Delivery: A Non-Inferiority Trial

ClinicalTrials.gov · NCT07636421 · Registry updated: 2026-10-09

Condition / research focus: Postpartum Hemorrhage; Uterine Atony; Cesarean Section; Blood Loss, Surgical
Sponsor: Mansoura University
Countries with listed sites: Saudi Arabia
Registry dates and results: Start: 2026-08-08. Completion: 2028-08 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin, Pabal
Oxytocin (drug) — also listed as: Syntocinon
Placebo Saline Infusion (drug) — also listed as: Normal Saline Placebo

Where the study takes place — 1 listed sites

Qassim University Medical City
Buraidah, Al-Qassim Region, Saudi Arabia
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

ClinicalTrials.gov · NCT06420297 · Registry updated: 2026-08-17

Condition / research focus: Hyperphagia in Prader-Willi Syndrome
Sponsor: ACADIA Pharmaceuticals Inc.
Countries with listed sites: Canada · France · Germany · Spain · United Kingdom · United States
Registry dates and results: Start: 2024-03-11. Completion: 2025-12-19 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: ACP-101

Where the study takes place — 30 listed sites

Children's of Alabama
Birmingham, Alabama, United States
Site recruitment: Not reported
Phoenix Children's Hospital
Phoenix, Arizona, United States
Site recruitment: Not reported
University of California Irvine
Orange, California, United States
Site recruitment: Not reported
Stanford University School of Medicine
Palo Alto, California, United States
Site recruitment: Not reported
Rady Children's Hospital San Diego
San Diego, California, United States
Site recruitment: Not reported
Children's Hospital Colorado
Aurora, Colorado, United States
Site recruitment: Not reported
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Site recruitment: Not reported
University of Iowa
Iowa City, Iowa, United States
Site recruitment: Not reported
Boston Children's Hospital
Boston, Massachusetts, United States
Site recruitment: Not reported
Children's Mercy Kansas City
Kansas City, Missouri, United States
Site recruitment: Not reported
SSM Health/Saint Louis University
St Louis, Missouri, United States
Site recruitment: Not reported
Maimonides Medical Center
Brooklyn, New York, United States
Site recruitment: Not reported
Nationwide Children's Hospital
Columbus, Ohio, United States
Site recruitment: Not reported
UPMC-Children's Hospital Pittsburgh
Pittsburgh, Pennsylvania, United States
Site recruitment: Not reported
Vanderbilt Clinical Research Center
Nashville, Tennessee, United States
Site recruitment: Not reported
Cook Children's Health Care System
Fort Worth, Texas, United States
Site recruitment: Not reported
Christus Children's
San Antonio, Texas, United States
Site recruitment: Not reported
University of Utah
Salt Lake City, Utah, United States
Site recruitment: Not reported
Seattle Children's Hospital
Seattle, Washington, United States
Site recruitment: Not reported
Alberta Diabetes Institute
Edmonton, Alberta, Canada
Site recruitment: Not reported
CHU Sainte-Justine
Montreal, Quebec, Canada
Site recruitment: Not reported
Centre Hospitalier Universitaire (CHU) de Toulouse - Hopital des Enfants
Toulouse, Cedex 9 Occitanie, France
Site recruitment: Not reported
KJF Klinik Josefinum gGmbH
Augsburg, Germany
Site recruitment: Not reported
Universitätsklinikum Essen
Essen, Germany
Site recruitment: Not reported
Parc Taulí Hospital Universitari
Barcelona, Spain
Site recruitment: Not reported
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Site recruitment: Not reported
Hospital Regional Universitario de Málaga
Málaga, Spain
Site recruitment: Not reported
University Hospitals Birmingham NHS Foundation Trust - Heartlands Hospital
Birmingham, United Kingdom
Site recruitment: Not reported
Royal Hospital for Children Glasgow Clinical
Glasgow, United Kingdom
Site recruitment: Not reported
Barts Health NHS Trust - The Royal London Hospital
London, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1Not yet recruitingINTERVENTIONAL

The Efficacy of Carbitocin in Reduction of Blood Loss During Myomectomy

ClinicalTrials.gov · NCT07721623 · Registry updated: 2026-07-23

Condition / research focus: Blood Loss, Surgical
Sponsor: Alex Ekwueme Federal University Teaching Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-08-15. Completion: 2028-08-14 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Injection water

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage

ClinicalTrials.gov · NCT07401524 · Registry updated: 2026-05-08

Condition / research focus: Postpartum Hemorrhage; Twin Pregnancy
Sponsor: Sheba Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2026-05-05. Completion: 2028-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Oxytocin (drug)

Where the study takes place — 1 listed sites

Sheba Medical Center
Ramat Gan, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium

ClinicalTrials.gov · NCT06285409 · Registry updated: 2026-04-06

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2024-04-04. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin
Oxytocin (drug) — also listed as: Pitocin
Carbetocin (drug) — also listed as: Duratocin
Oxytocin (drug) — also listed as: Pitocin
Ergonovine (drug) — also listed as: Ergometrine
Carboprost (drug) — also listed as: Hemabate

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery

ClinicalTrials.gov · NCT06333340 · Registry updated: 2026-04-01

Condition / research focus: Post Partum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2025-01-14. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Carbetocin (drug) — also listed as: Duratocin

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Effect of Co-administration of Carbetocin and Calcium Chloride on Uterine Tone in Patients Undergoing Elective Cesarean Delivery

ClinicalTrials.gov · NCT07187544 · Registry updated: 2026-04-01

Condition / research focus: Postpartum Hemorrhage (Primary)
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2025-12-01. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Calcium Chloride (drug)
Placebo (other)
Carbetocin (drug)

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparison of the Effect of Carbetocin Versus Oxytocin in the Prevention of Postpartum Hemorrhage After Emergency Caesarean Section in Antenatal Low-risk Patients

ClinicalTrials.gov · NCT07380529 · Registry updated: 2026-02-13

Condition / research focus: Postpartum Hemorrhage \(PPH\)
Sponsor: Ankara Etlik City Hospital
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2024-10-01. Completion: 2025-08-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)
Oxytocin (drug)

Where the study takes place — 2 listed sites

Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye)
Site recruitment: Not reported
Etlik City Hospital
Ankara, Yenimahalle, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Carbetocin Myocardium Trial 2014 Part 2

ClinicalTrials.gov · NCT03899961 · Registry updated: 2026-02-10

Condition / research focus: Pregnancy Complications
Sponsor: Oslo University Hospital
Countries with listed sites: Norway
Registry dates and results: Start: 2019-04-02. Completion: 2022-04-15 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Carbetocin (drug)

Where the study takes place — 2 listed sites

Akershus University Hospital
Lørenskog, Norway
Site recruitment: Not reported
Division of Anaesthesia and Intensive Care Medicine, Oslo University Hospital - Rikshospitalet
Oslo, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Ergometrine Versus Carbetocin to Decrease Blood Loss in Myomectomy

ClinicalTrials.gov · NCT07390864 · Registry updated: 2026-02-05

Condition / research focus: Myoma;Uterus
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2026-01-18. Completion: 2026-08-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Methylergometrine (Intramyometrial Injection) (drug) — also listed as: Methylergometrine maleate, Ergometrine, Methergine
Carbetocin (Intramyometrial Injection) (drug) — also listed as: Carbetocin, Long-acting oxytocin analogue

Where the study takes place — 1 listed sites

Fayoum University
Al Fayyum, Faiyum Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Carbetocin vs Misoprostol for Postpartum Hemorrhage Prevention

ClinicalTrials.gov · NCT07353281 · Registry updated: 2026-01-20

Condition / research focus: Postpartum Complication; Postpartum Hemorrhage
Sponsor: Western Galilee Hospital-Nahariya
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-01-31. Completion: 2028-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin 100 Microgram/mL Solution for Injection (drug)
Misoprostol (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone

ClinicalTrials.gov · NCT07318467 · Registry updated: 2026-01-06

Condition / research focus: Post Partum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-01-01. Completion: 2026-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative (drug)
Intravenous Carbetocin alone (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium

ClinicalTrials.gov · NCT06930391 · Registry updated: 2025-09-24

Condition / research focus: Postpartum Hemorrhage (Primary)
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2025-09-15. Completion: 2026-06 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Carbetocin (drug)
Calcium (drug)

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Timing of Carbetocin Administration in Postpartum Hemorrhage

ClinicalTrials.gov · NCT06776926 · Registry updated: 2025-09-18

Condition / research focus: Postpartum Hemorrhage; Carbetocin
Sponsor: Mehmet Mete Kırlangıç
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2025-01-10. Completion: 2025-02-28 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (behavioral)

Where the study takes place — 1 listed sites

Kartal Dr Lutfi Kirdar City Hospital
Istanbul, Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

To Compare the Effects of Oxytocin and Carbetocin on Intraoperative Hemodynamic Changes in Cesarean Section Surgeries.

ClinicalTrials.gov · NCT06956365 · Registry updated: 2025-05-04

Condition / research focus: Cesarean Section
Sponsor: Yuzuncu Yil University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2024-05-14. Completion: 2025-07-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Group-C (procedure) — also listed as: Group Carbetosin
Group-O (procedure) — also listed as: Group Oxytocine

Where the study takes place — 1 listed sites

Van Yuzuncu Yil University
Van, Tuşba, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4Not yet recruitingINTERVENTIONAL

Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section

ClinicalTrials.gov · NCT06946589 · Registry updated: 2025-04-27

Condition / research focus: Cardiac Ischemia; Cesarian Section
Sponsor: Jordan Leitch
Countries with listed sites: Canada
Registry dates and results: Start: 2025-08-01. Completion: 2027-09-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug)

Where the study takes place — 1 listed sites

Kingston Health Sciences Centre
Kingston, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Carbetocin at Elective Cesarean Delivery

ClinicalTrials.gov · NCT01262742 · Registry updated: 2025-04-25

Condition / research focus: Postpartum Hemorrhage
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2010-11. Completion: 2011-03 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Duratocin
Carbetocin (drug) — also listed as: Duratocin
Carbetocin (drug) — also listed as: Duratocin
Carbetocin (drug) — also listed as: Duratocin
Carbetocin (drug) — also listed as: Duratocin

Where the study takes place — 1 listed sites

Mount Sinai Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

ClinicalTrials.gov · NCT01968187 · Registry updated: 2025-03-27

Condition / research focus: Hyperphagia in Prader-Willi Syndrome
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2014-01-20. Completion: 2014-07-16 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

FE 992097 (drug)
Placebo (drug)

Where the study takes place — 3 listed sites

Florida University
Gainesville, Florida, United States
Site recruitment: Not reported
Winthrop University
Mineola, New York, United States
Site recruitment: Not reported
Vanderbilt University
Nashville, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative Pain

ClinicalTrials.gov · NCT06692621 · Registry updated: 2025-03-24

Condition / research focus: PREG1
Sponsor: Ankara City Hospital Bilkent
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2024-10-04. Completion: 2025-01-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Deva İlaç Sanayi, Turkey
Carbetocin (drug) — also listed as: Ferring GmbH, Germany

Where the study takes place — 1 listed sites

Ankara Bilkent City Hospital
Ankara, Ankara, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →